arrow
E

Elham Sajjadi

European Institute of Oncology IRCCS
H指数:23
被引数:1,651

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Aberrant cytoplasmic localization of MLH1 characterizes a cell population that seeds breast cancer recurrence

MLH1的异常细胞质定位特征了一种能够引发乳腺癌复发的细胞群体

2025-12-100
OA
Decoding the immune landscape of breast cancer (BC) during pregnancy (PrBC): Impact of hormone receptors (HR) and tumor-infiltrating lymphocytes (TILs) phenotype on gene expression signatures
2024-05-020
PRE
CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype

遗传性小叶性乳腺癌女性CDH1基因型研究

2024-04-230
OAAI
Heterogeneity of ER, PgR, HER2 and Ki67 in multifocal/multicentric breast cancer with a single histotype and same grade: implications for pathologists and oncologists from a large multi-institutional series
2024-03-010
PRE
Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study
2023-12-010
PRE
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey
2023-10-014
PRE
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer

符合2023 ASCO/CAP更新和2023 ESMO HER2-low乳腺癌共识声明的HER2检测标准化病理报告

2023-09-2831
OAAI
An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples
2023-02-084
OAAI
Analytical Performance of Next-Generation Sequencing and RT-PCR on Formalin-Fixed Paraffin-Embedded Tumor Tissues for PIK3CA Testing in HR+/HER2-Breast Cancer
CELLS
IF5.2
2022-11-0911
OAAI